ESPERITE convenes Annual General Meeting of Shareholders
Esperite N.V. announces that it has convened its Annual General Meeting of Shareholders (“AGM”) to be held on Wednesday 17 June 2015.
Zutphen, the Netherlands – 6 May 2015
At the AGM, the Company’s Executive Director and CEO Mr. Frédéric Amar will inter alia discuss the Company’s performance and achievements over 2014 and its plans and forecasts for 2015.
The AGM’s convocation notice, agenda and the explanatory notes to the agenda and the further AGM materials are available free of charge at the Company’s offices in Zutphen, the Netherlands, and can be downloaded from the Company’s website www.esperite.com.
Shareholders that are interested in attending the AGM are invited to contact the Company at: +31 575 548 998 – firstname.lastname@example.org.
ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and predictive medicine since 2000, operational in 40 countries with a network of 6,000 clinics worldwide. ESPERITE serves clients in its state-of-the-art lab facilities in Geneva coupled with ultra-modern processing and storage facilities in Belgium, Switzerland, Germany, Dubai, South Africa and Portugal. Its family stem cell bank, CryoSave, stores almost 275,000 samples from umbilical cord blood and cord tissue.